{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:43:11Z","timestamp":1780472591999,"version":"3.54.1"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,10,5]],"date-time":"2018-10-05T00:00:00Z","timestamp":1538697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,10,5]],"date-time":"2018-10-05T00:00:00Z","timestamp":1538697600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000069","name":"U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R00 AR062047, R01 AR068970 and R01 AR071463"],"award-info":[{"award-number":["R00 AR062047, R01 AR068970 and R01 AR071463"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Targeting microRNAs recently shows significant therapeutic promise; however, such progress is underdeveloped in treatment of skeletal diseases with osteolysis, such as osteoporosis and rheumatoid arthritis (RA). Here,\u00a0we identified miR-182 as a key osteoclastogenic regulator in bone homeostasis and diseases. Myeloid-specific deletion of miR-182 protects mice against excessive osteoclastogenesis and bone resorption in disease models of ovariectomy-induced osteoporosis and inflammatory arthritis. Pharmacological treatment of these diseases with miR-182 inhibitors completely suppresses pathologic bone erosion. Mechanistically, we identify protein kinase double-stranded RNA-dependent (PKR) as a new and essential miR-182 target that is a novel inhibitor of osteoclastogenesis via regulation of the endogenous interferon (IFN)-\u03b2-mediated autocrine feedback loop. The expression levels of miR-182, PKR, and IFN-\u03b2 are altered in RA and are significantly correlated with the osteoclastogenic capacity of RA monocytes. Our findings reveal a previously unrecognized regulatory network mediated by miR-182-PKR-IFN-\u03b2 axis in osteoclastogenesis, and highlight the therapeutic implications of miR-182 inhibition in osteoprotection.<\/jats:p>","DOI":"10.1038\/s41467-018-06446-0","type":"journal-article","created":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T13:40:21Z","timestamp":1538401221000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":77,"title":["Bone protection by inhibition of microRNA-182"],"prefix":"10.1038","volume":"9","author":[{"given":"Kazuki","family":"Inoue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhonghao","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenia","family":"Giannopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6578-4553","authenticated-orcid":false,"given":"Ren","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiaoching","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew B.","family":"Greenblatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingegowda S.","family":"Mangala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Lopez-Berestein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David G.","family":"Kirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil K.","family":"Sood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1286-0919","authenticated-orcid":false,"given":"Baohong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,5]]},"reference":[{"key":"6446_CR1","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1196\/annals.1402.084","volume":"1116","author":"BF Boyce","year":"2007","unstructured":"Boyce, B. F. et al. New roles for osteoclasts in bone. Ann. N.Y. Acad. Sci. 1116, 245\u2013254 (2007).","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"6446_CR2","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/nrrheum.2009.175","volume":"5","author":"Y Choi","year":"2009","unstructured":"Choi, Y., Arron, J. R. & Townsend, M. J. Promising bone-related therapeutic targets for rheumatoid arthritis. Nat. Rev. Rheumatol. 5, 543\u2013548 (2009).","journal-title":"Nat. Rev. Rheumatol."},{"key":"6446_CR3","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1146\/annurev.pathmechdis.3.121806.151431","volume":"3","author":"DV Novack","year":"2008","unstructured":"Novack, D. V. & Teitelbaum, S. L. The osteoclast: friend or foe? Annu. Rev. Pathol. 3, 457\u2013484 (2008).","journal-title":"Annu. Rev. Pathol."},{"key":"6446_CR4","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1097\/01.bor.0000231912.24740.a5","volume":"18","author":"K Sato","year":"2006","unstructured":"Sato, K. & Takayanagi, H. Osteoclasts rheumatoid arthritis, and osteoimmunology. Curr. Opin. Rheumatol. 18, 419\u2013426 (2006).","journal-title":"Curr. Opin. Rheumatol."},{"key":"6446_CR5","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/nrrheum.2012.153","volume":"8","author":"G Schett","year":"2012","unstructured":"Schett, G. & Gravallese, E. Bone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatment. Nat. Rev. Rheumatol. 8, 656\u2013664 (2012).","journal-title":"Nat. Rev. Rheumatol."},{"key":"6446_CR6","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/ar1857","volume":"8","author":"SL Teitelbaum","year":"2006","unstructured":"Teitelbaum, S. L. Osteoclasts; culprits in inflammatory osteolysis. Arthritis Res. Ther. 8, 201 (2006).","journal-title":"Arthritis Res. Ther."},{"key":"6446_CR7","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"Bartel, D. P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281\u2013297 (2004).","journal-title":"Cell"},{"key":"6446_CR8","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.molmed.2014.06.005","volume":"20","author":"J Hayes","year":"2014","unstructured":"Hayes, J., Peruzzi, P. P. & Lawler, S. MicroRNAs in cancer: biomarkers, functions and therapy. Trends Mol. Med. 20, 460\u2013469 (2014).","journal-title":"Trends Mol. Med."},{"key":"6446_CR9","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/nrg1379","volume":"5","author":"L He","year":"2004","unstructured":"He, L. & Hannon, G. J. MicroRNAs: small RNAs with a big role in gene regulation. Nat. Rev. Genet. 5, 522\u2013531 (2004).","journal-title":"Nat. Rev. Genet."},{"key":"6446_CR10","doi-asserted-by":"publisher","first-page":"re2","DOI":"10.1126\/scisignal.2005813","volume":"8","author":"V Olive","year":"2015","unstructured":"Olive, V., Minella, A. C. & He, L. Outside the coding genome, mammalian microRNAs confer structural and functional complexity. Sci. Signal. 8, re2 (2015).","journal-title":"Sci. Signal."},{"key":"6446_CR11","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/j.autrev.2013.07.003","volume":"12","author":"RP Singh","year":"2013","unstructured":"Singh, R. P. et al. The role of miRNA in inflammation and autoimmunity. Autoimmun. Rev. 12, 1160\u20131165 (2013).","journal-title":"Autoimmun. Rev."},{"key":"6446_CR12","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/j.1582-4934.2008.00534.x","volume":"13","author":"E Sonkoly","year":"2009","unstructured":"Sonkoly, E. & Pivarcsi, A. Advances in microRNAs: implications for immunity and inflammatory diseases. J. Cell. Mol. Med. 13, 24\u201338 (2009).","journal-title":"J. Cell. Mol. Med."},{"key":"6446_CR13","doi-asserted-by":"publisher","first-page":"930","DOI":"10.7150\/thno.7026","volume":"3","author":"S Srinivasan","year":"2013","unstructured":"Srinivasan, S., Selvan, S. T., Archunan, G., Gulyas, B. & Padmanabhan, P. MicroRNAs\u2014the next generation therapeutic targets in human diseases. Theranostics 3, 930\u2013942 (2013).","journal-title":"Theranostics"},{"key":"6446_CR14","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1002\/art.23386","volume":"58","author":"J Stanczyk","year":"2008","unstructured":"Stanczyk, J. et al. Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis. Arthritis Rheum. 58, 1001\u20131009 (2008).","journal-title":"Arthritis Rheum."},{"key":"6446_CR15","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nrd.2016.246","volume":"16","author":"R Rupaimoole","year":"2017","unstructured":"Rupaimoole, R. & Slack, F. J. MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Nat. Rev. Drug Discov. 16, 203\u2013222 (2017).","journal-title":"Nat. Rev. Drug Discov."},{"key":"6446_CR16","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.omtn.2017.06.005","volume":"8","author":"C Chakraborty","year":"2017","unstructured":"Chakraborty, C., Sharma, A. R., Sharma, G., Doss, C. G. P. & Lee, S. S. Therapeutic miRNA and siRNA: Moving from Bench to Clinic as Next Generation Medicine. Mol. Ther. Nucleic Acids 8, 132\u2013143 (2017).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"6446_CR17","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1056\/NEJMoa1209026","volume":"368","author":"HL Janssen","year":"2013","unstructured":"Janssen, H. L. et al. Treatment of HCV infection by targeting microRNA. N. Engl. J. Med. 368, 1685\u20131694 (2013).","journal-title":"N. Engl. J. Med."},{"key":"6446_CR18","doi-asserted-by":"publisher","first-page":"2991","DOI":"10.1093\/hmg\/dds129","volume":"21","author":"Y Bae","year":"2012","unstructured":"Bae, Y. et al. miRNA-34c regulates Notch signaling during bone development. Hum. Mol. Genet. 21, 2991\u20133000 (2012).","journal-title":"Hum. Mol. Genet."},{"key":"6446_CR19","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.coph.2014.05.001","volume":"16","author":"KM Kim","year":"2014","unstructured":"Kim, K. M. & Lim, S. K. Role of miRNAs in bone and their potential as therapeutic targets. Curr. Opin. Pharmacol. 16, 133\u2013141 (2014).","journal-title":"Curr. Opin. Pharmacol."},{"key":"6446_CR20","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/nature13375","volume":"512","author":"JY Krzeszinski","year":"2014","unstructured":"Krzeszinski, J. Y. et al. miR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and Tgif2. Nature 512, 431\u2013435 (2014).","journal-title":"Nature"},{"key":"6446_CR21","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1083\/jcb.201201057","volume":"197","author":"J Wei","year":"2012","unstructured":"Wei, J. et al. miR-34s inhibit osteoblast proliferation and differentiation in the mouse by targeting SATB2. J. Cell Biol. 197, 509\u2013521 (2012).","journal-title":"J. Cell Biol."},{"key":"6446_CR22","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/nsmb.2296","volume":"19","author":"MR Fabian","year":"2012","unstructured":"Fabian, M. R. & Sonenberg, N. The mechanics of miRNA-mediated gene silencing: a look under the hood of miRISC. Nat. Struct. Mol. Biol. 19, 586\u2013593 (2012).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"6446_CR23","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/nrg3965","volume":"16","author":"S Jonas","year":"2015","unstructured":"Jonas, S. & Izaurralde, E. Toward a molecular understanding of microRNA-mediated gene silencing. Nat. Rev. Genet. 16, 421\u2013433 (2015).","journal-title":"Nat. Rev. Genet."},{"key":"6446_CR24","doi-asserted-by":"publisher","first-page":"4977","DOI":"10.4049\/jimmunol.1502044","volume":"196","author":"CH Miller","year":"2016","unstructured":"Miller, C. H. et al. RBP-J-regulated miR-182 promotes TNF-alpha-induced osteoclastogenesis. J. Immunol. 196, 4977\u20134986 (2016).","journal-title":"J. Immunol."},{"key":"6446_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13884","volume":"7","author":"J Yu","year":"2016","unstructured":"Yu, J. et al. MicroRNA-182 targets SMAD7 to potentiate TGFbeta-induced epithelial\u2013mesenchymal transition and metastasis of cancer cells. Nat. Commun. 7, 13884 (2016).","journal-title":"Nat. Commun."},{"key":"6446_CR26","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1101\/gad.257394.114","volume":"29","author":"FM Kouri","year":"2015","unstructured":"Kouri, F. M. et al. miR-182 integrates apoptosis, growth, and differentiation programs in glioblastoma. Genes Dev. 29, 732\u2013745 (2015).","journal-title":"Genes Dev."},{"key":"6446_CR27","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1261\/rna.034926.112","volume":"19","author":"K Krishnan","year":"2013","unstructured":"Krishnan, K. et al. MicroRNA-182-5p targets a network of genes involved in DNA repair. RNA 19, 230\u2013242 (2013).","journal-title":"RNA"},{"key":"6446_CR28","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1038\/onc.2013.65","volume":"33","author":"R Lei","year":"2014","unstructured":"Lei, R. et al. Suppression of MIM by microRNA-182 activates RhoA and promotes breast cancer metastasis. Oncogene 33, 1287\u20131296 (2014).","journal-title":"Oncogene"},{"key":"6446_CR29","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1128\/MCB.01043-13","volume":"34","author":"XL Li","year":"2014","unstructured":"Li, X. L. et al. A p21-ZEB1 complex inhibits epithelial\u2013mesenchymal transition through the microRNA 183-96-182 cluster. Mol. Cell Biol. 34, 533\u2013550 (2014).","journal-title":"Mol. Cell. Biol."},{"key":"6446_CR30","doi-asserted-by":"publisher","first-page":"4305","DOI":"10.1172\/JCI77116","volume":"124","author":"M Sachdeva","year":"2014","unstructured":"Sachdeva, M. et al. MicroRNA-182 drives metastasis of primary sarcomas by targeting multiple genes. J. Clin. Invest. 124, 4305\u20134319 (2014).","journal-title":"J. Clin. Invest."},{"key":"6446_CR31","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1073\/pnas.0808263106","volume":"106","author":"MF Segura","year":"2009","unstructured":"Segura, M. F. et al. Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor. Proc. Natl Acad. Sci. USA 106, 1814\u20131819 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"6446_CR32","doi-asserted-by":"publisher","first-page":"3563","DOI":"10.1172\/JCI62339","volume":"122","author":"L Song","year":"2012","unstructured":"Song, L. et al. TGF-beta induces miR-182 to sustain NF-kappaB activation in glioma subsets. J. Clin. Invest. 122, 3563\u20133578 (2012).","journal-title":"J. Clin. Invest."},{"key":"6446_CR33","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1038\/ni.1945","volume":"11","author":"AB Stittrich","year":"2010","unstructured":"Stittrich, A. B. et al. The microRNA miR-182 is induced by IL-2 and promotes clonal expansion of activated helper T lymphocytes. Nat. Immunol. 11, 1057\u20131062 (2010).","journal-title":"Nat. Immunol."},{"key":"6446_CR34","doi-asserted-by":"publisher","first-page":"10356","DOI":"10.1093\/nar\/gks750","volume":"40","author":"B Yu","year":"2012","unstructured":"Yu, B. et al. miR-182 inhibits Schwann cell proliferation and migration by targeting FGF9 and NTM, respectively at an early stage following sciatic nerve injury. Nucleic Acids Res. 40, 10356\u201310365 (2012).","journal-title":"Nucleic Acids Res."},{"key":"6446_CR35","doi-asserted-by":"publisher","first-page":"4858","DOI":"10.1074\/jbc.275.7.4858","volume":"275","author":"Y Azuma","year":"2000","unstructured":"Azuma, Y., Kaji, K., Katogi, R., Takeshita, S. & Kudo, A. Tumor necrosis factor-alpha induces differentiation of and bone resorption by osteoclasts. J. Biol. Chem. 275, 4858\u20134864 (2000).","journal-title":"J. Biol. Chem."},{"key":"6446_CR36","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1097\/01.bor.0000231913.32364.32","volume":"18","author":"BF Boyce","year":"2006","unstructured":"Boyce, B. F., Schwarz, E. M. & Xing, L. Osteoclast precursors: cytokine-stimulated immunomodulators of inflammatory bone disease. Curr. Opin. Rheumatol. 18, 427\u2013432 (2006).","journal-title":"Curr. Opin. Rheumatol."},{"key":"6446_CR37","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1084\/jem.20050978","volume":"202","author":"N Kim","year":"2005","unstructured":"Kim, N. et al. Osteoclast differentiation independent of the TRANCE-RANK-TRAF6 axis. J. Exp. Med. 202, 589\u2013595 (2005).","journal-title":"J. Exp. Med."},{"key":"6446_CR38","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1172\/JCI11176","volume":"106","author":"J Lam","year":"2000","unstructured":"Lam, J. et al. TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J. Clin. Invest. 106, 1481\u20131488 (2000).","journal-title":"J. Clin. Invest."},{"key":"6446_CR39","doi-asserted-by":"publisher","first-page":"11846","DOI":"10.1074\/jbc.M512624200","volume":"281","author":"Z Yao","year":"2006","unstructured":"Yao, Z. et al. Tumor necrosis factor-alpha increases circulating osteoclast precursor numbers by promoting their proliferation and differentiation in the bone marrow through upregulation of c-Fms expression. J. Biol. Chem. 281, 11846\u201311855 (2006).","journal-title":"J. Biol. Chem."},{"key":"6446_CR40","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1007\/s11914-017-0358-z","volume":"15","author":"B Zhao","year":"2017","unstructured":"Zhao, B. TNF and Bone Remodeling. Curr. Osteoporos. Rep. 15, 126\u2013134 (2017).","journal-title":"Curr. Osteoporos. Rep."},{"key":"6446_CR41","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1073\/pnas.97.4.1566","volume":"97","author":"J Li","year":"2000","unstructured":"Li, J. et al. RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism. Proc. Natl Acad. Sci. USA 97, 1566\u20131571 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"6446_CR42","doi-asserted-by":"publisher","first-page":"3436","DOI":"10.4049\/jimmunol.1601716","volume":"198","author":"N Binder","year":"2017","unstructured":"Binder, N. et al. Def6 restrains osteoclastogenesis and inflammatory bone resorption. J. Immunol. 198, 3436\u20133447 (2017).","journal-title":"J. Immunol."},{"key":"6446_CR43","doi-asserted-by":"publisher","first-page":"5057","DOI":"10.1172\/JCI71882","volume":"124","author":"S Li","year":"2014","unstructured":"Li, S. et al. RBP-J imposes a requirement for ITAM-mediated costimulation of osteoclastogenesis. J. Clin. Invest. 124, 5057\u20135073 (2014).","journal-title":"J. Clin. Invest."},{"key":"6446_CR44","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/416744a","volume":"416","author":"H Takayanagi","year":"2002","unstructured":"Takayanagi, H. et al. RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-beta. Nature 416, 744\u2013749 (2002).","journal-title":"Nature"},{"key":"6446_CR45","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1084\/jem.20111566","volume":"209","author":"B Zhao","year":"2012","unstructured":"Zhao, B., Grimes, S. N., Li, S., Hu, X. & Ivashkiv, L. B. TNF-induced osteoclastogenesis and inflammatory bone resorption are inhibited by transcription factor RBP-. J. Exp. Med. 209, 319\u2013334 (2012).","journal-title":"J. Exp. Med."},{"key":"6446_CR46","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1038\/nm.2007","volume":"15","author":"B Zhao","year":"2009","unstructured":"Zhao, B. et al. Interferon regulatory factor-8 regulates bone metabolism by suppressing osteoclastogenesis. Nat. Med. 15, 1066\u20131071 (2009).","journal-title":"Nat. Med."},{"key":"6446_CR47","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/S0092-8674(00)81989-3","volume":"87","author":"V Kouskoff","year":"1996","unstructured":"Kouskoff, V. et al. Organ-specific disease provoked by systemic autoimmunity. Cell 87, 811\u2013822 (1996).","journal-title":"Cell"},{"key":"6446_CR48","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.jconrel.2013.08.005","volume":"172","author":"H Ragelle","year":"2013","unstructured":"Ragelle, H., Vandermeulen, G. & Preat, V. Chitosan-based siRNA delivery systems. J. Control. Release 172, 207\u2013218 (2013).","journal-title":"J. Control. Release"},{"key":"6446_CR49","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.2217\/nnm.14.162","volume":"9","author":"H Baigude","year":"2014","unstructured":"Baigude, H. & Rana, T. M. Strategies to antagonize miRNA functions in vitro and in vivo. Nanomedicine 9, 2545\u20132555 (2014).","journal-title":"Nanomedicine"},{"key":"6446_CR50","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1517\/17425247.2013.798640","volume":"10","author":"M Muthiah","year":"2013","unstructured":"Muthiah, M., Park, I. K. & Cho, C. S. Nanoparticle-mediated delivery of therapeutic genes: focus on miRNA therapeutics. Expert. Opin. Drug. Deliv. 10, 1259\u20131273 (2013).","journal-title":"Expert. Opin. Drug. Deliv."},{"key":"6446_CR51","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/ni1576","volume":"9","author":"A Yarilina","year":"2008","unstructured":"Yarilina, A., Park-Min, K. H., Antoniv, T., Hu, X. & Ivashkiv, L. B. TNF activates an IRF1-dependent autocrine loop leading to sustained expression of chemokines and STAT1-dependent type I interferon-response genes. Nat. Immunol. 9, 378\u2013387 (2008).","journal-title":"Nat. Immunol."},{"key":"6446_CR52","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/ar3379","volume":"13","author":"B Zhao","year":"2011","unstructured":"Zhao, B. & Ivashkiv, L. B. Negative regulation of osteoclastogenesis and bone resorption by cytokines and transcriptional repressors. Arthritis Res. Ther. 13, 234 (2011).","journal-title":"Arthritis Res. Ther."},{"key":"6446_CR53","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.virol.2005.09.024","volume":"344","author":"O Haller","year":"2006","unstructured":"Haller, O., Kochs, G. & Weber, F. The interferon-response circuit: induction and suppression by pathogenic viruses. Virology 344, 119\u2013130 (2006).","journal-title":"Virology"},{"key":"6446_CR54","doi-asserted-by":"publisher","first-page":"85","DOI":"10.4161\/viru.23134","volume":"4","author":"M Munir","year":"2013","unstructured":"Munir, M. & Berg, M. The multiple faces of protein kinase R in antiviral defense. Virulence 4, 85\u201389 (2013).","journal-title":"Virulence"},{"key":"6446_CR55","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/0092-8674(90)90374-N","volume":"62","author":"E Meurs","year":"1990","unstructured":"Meurs, E. et al. Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon. Cell 62, 379\u2013390 (1990).","journal-title":"Cell"},{"key":"6446_CR56","doi-asserted-by":"publisher","first-page":"36384","DOI":"10.1074\/jbc.M112.390039","volume":"287","author":"CS McAllister","year":"2012","unstructured":"McAllister, C. S., Taghavi, N. & Samuel, C. E. Protein kinase PKR amplification of interferon beta induction occurs through initiation factor eIF-2alpha-mediated translational control. J. Biol. Chem. 287, 36384\u201336392 (2012).","journal-title":"J. Biol. Chem."},{"key":"6446_CR57","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.virol.2012.01.029","volume":"427","author":"N Taghavi","year":"2012","unstructured":"Taghavi, N. & Samuel, C. E. Protein kinase PKR catalytic activity is required for the PKR-dependent activation of mitogen-activated protein kinases and amplification of interferon beta induction following virus infection. Virology 427, 208\u2013216 (2012).","journal-title":"Virology"},{"key":"6446_CR58","doi-asserted-by":"publisher","first-page":"3449","DOI":"10.1091\/mbc.e10-06-0481","volume":"21","author":"X Yang","year":"2010","unstructured":"Yang, X., Nath, A., Opperman, M. J. & Chan, C. The double-stranded RNA-dependent protein kinase differentially regulates insulin receptor substrates 1 and 2 in HepG2 cells. Mol. Biol. Cell 21, 3449\u20133458 (2010).","journal-title":"Mol. Biol. Cell"},{"key":"6446_CR59","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1002\/stem.7","volume":"27","author":"CA Opitz","year":"2009","unstructured":"Opitz, C. A. et al. Toll-like receptor engagement enhances the immunosuppressive properties of human bone marrow-derived mesenchymal stem cells by inducing indoleamine-2,3-dioxygenase-1 via interferon-beta and protein kinase R. Stem Cells 27, 909\u2013919 (2009).","journal-title":"Stem Cells"},{"key":"6446_CR60","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.cmet.2013.11.002","volume":"18","author":"MV Lourenco","year":"2013","unstructured":"Lourenco, M. V. et al. TNF-alpha mediates PKR-dependent memory impairment and brain IRS-1 inhibition induced by Alzheimer\u2019s beta-amyloid oligomers in mice and monkeys. Cell Metab. 18, 831\u2013843 (2013).","journal-title":"Cell Metab."},{"key":"6446_CR61","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nature02405","volume":"428","author":"LC Hsu","year":"2004","unstructured":"Hsu, L. C. et al. The protein kinase PKR is required for macrophage apoptosis after activation of Toll-like receptor 4. Nature 428, 341\u2013345 (2004).","journal-title":"Nature"},{"issue":"4","key":"6446_CR62","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3390\/pharmaceutics9040053","volume":"9","author":"Munawar Mohammed","year":"2017","unstructured":"Mohammed M. A., Syeda J. T. M., Wasan K. M., Wasan E. K. An overview of chitosan nanoparticles and its application in non-parenteral drug delivery. Pharmaceutics 9, 53\u201379 (2017).","journal-title":"Pharmaceutics"},{"key":"6446_CR63","doi-asserted-by":"publisher","first-page":"5953","DOI":"10.1074\/jbc.274.9.5953","volume":"274","author":"N Abraham","year":"1999","unstructured":"Abraham, N. et al. Characterization of transgenic mice with targeted disruption of the catalytic domain of the double-stranded RNA-dependent protein kinase, PKR. J. Biol. Chem. 274, 5953\u20135962 (1999).","journal-title":"J. Biol. Chem."},{"key":"6446_CR64","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1002\/jbmr.141","volume":"25","author":"ML Bouxsein","year":"2010","unstructured":"Bouxsein, M. L. et al. Guidelines for assessment of bone microstructure in rodents using microcomputed tomography. J. Bone Mineral Res. 25, 1468\u20131486 (2010).","journal-title":"J. Bone Mineral Res."},{"key":"6446_CR65","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1093\/bioinformatics\/btp120","volume":"25","author":"C Trapnell","year":"2009","unstructured":"Trapnell, C., Pachter, L. & Salzberg, S. L. TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 25, 1105\u20131111 (2009).","journal-title":"Bioinformatics"},{"key":"6446_CR66","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.3317","volume":"12","author":"D Kim","year":"2015","unstructured":"Kim, D., Langmead, B. & Salzberg, S. L. HISAT: a fast spliced aligner with low memory requirements. Nat. Methods 12, 357\u2013360 (2015).","journal-title":"Nat. Methods"},{"key":"6446_CR67","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/nbt.1621","volume":"28","author":"C Trapnell","year":"2010","unstructured":"Trapnell, C. et al. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat. Biotechnol. 28, 511\u2013515 (2010).","journal-title":"Nat. Biotechnol."},{"key":"6446_CR68","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","volume":"31","author":"S Anders","year":"2015","unstructured":"Anders, S., Pyl, P. T. & Huber, W. HTSeq\u2014a Python framework to work with high-throughput sequencing data. Bioinformatics 31, 166\u2013169 (2015).","journal-title":"Bioinformatics"},{"key":"6446_CR69","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139\u2013140 (2010).","journal-title":"Bioinformatics"},{"key":"6446_CR70","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1101\/gr.772403","volume":"13","author":"PD Thomas","year":"2003","unstructured":"Thomas, P. D. et al. PANTHER: a library of protein families and subfamilies indexed by function. Genome Res. 13, 2129\u20132141 (2003).","journal-title":"Genome Res."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-06446-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-06446-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-06446-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T18:43:30Z","timestamp":1671561810000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-06446-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,5]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["6446"],"URL":"https:\/\/doi.org\/10.1038\/s41467-018-06446-0","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,5]]},"assertion":[{"value":"13 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4108"}}